Study identifies brain cells key to understanding other people
Researchers at WashU Medicine Mallinckrodt Institute of Radiology have identified specific neuronal cells that are essential to our understanding of other people.
WashU Medicine launches center for rare diseases
WashU Medicine has launched the Center for Rare, Undiagnosed and Genetic Diseases, which brings together researchers and patient communities to create a collaborative network to drive innovative research and accelerate drug discovery.
Garcia to study protein arginylation
Benjamin Garcia, the Raymond H. Wittcoff Distinguished Professor at WashU Medicine, along with colleagues Zongtao (Tom) Lin and Dongwen Lyu, received a four-year $2.4 million grant renewal from the National Heart, Lung and Blood Institute, part of the National Institutes of Health (NIH).
Study highlights barriers to genetic testing for Black children
A recent study by WashU Medicine researchers found Black children were about half as likely as white children to obtain genetic testing ordered by their neurologists.
Next-gen Alzheimer’s drugs extend independent living by months
An analysis by researchers at WashU Medicine interprets the benefits of new Alzheimer’s drugs in a way that aims to help patients and families make informed treatment decisions.
Rutledge-Jukes named to Forbes’ ’30 under 30′
Heath Rutledge-Jukes, 25, a second-year student at WashU Medicine, has earned a spot on Forbes’ “30 Under 30” education list.
Mwirigi awarded HHMI fellowship for exceptional early-career scientists
Neuroscientist Juliet Mwirigi, a postdoctoral researcher in the Department of Anesthesiology at WashU Medicine, has been named a Hanna H. Gray Fellow by the Howard Hughes Medical Institute.
Patient defies genetic fate to avoid Alzheimer’s
A Washington man who inherited a mutation that should have caused him to develop Alzheimer’s decades ago remains mentally sharp. A new study of his case by researchers at WashU Medicine aims to identify potential routes to preventing or treating the disease.
WashU Medicine and Weizmann Institute of Science establish joint research program
WashU Medicine and the Weizmann Institute of Science have launched a collaboration to support joint research projects focused on understanding the role of microbes and the immune and nervous systems in human health and disease.
Nasal COVID-19 vaccine based on WashU technology to enter U.S. clinical trials
A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S.
View More Stories